Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: O2-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation
Fenghua Kanga,
Jiayi Zhua,
Jianbing Wua,
Tian Lva,
Hua Xiang
b,
Jide Tianc,
Yihua Zhang*a and
Zhangjian Huang*a
aState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China. E-mail: zyhtgd@163.com; zhangjianhuang@cpu.edu.cn
bDepartment of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
cDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, California 90095, USA
First published on 6th January 2020
Abstract
Correction for ‘O2-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation’ by Fenghua Kang et al., Chem. Sci., 2018, 9, 6893–6898.
The authors regret that in the original article two incorrect images were used in Fig. 4b for representing migration tumor cells in the control and TGF-β + 3f (20 nM) groups, and two incorrect images were used in Fig. 4c for representing invasive tumor cells in the TGF-β + 3f (10 nM) and TGF-β + 3f (20 nM) groups.
 | ||
| Fig. 4 (a) 3f inhibited adhesion of MDA-MB-231 cells to HUVECs: fluorescence microscopy showed MDA-MB-231 cells (green) adhered to the HUVECs. **P < 0.01. (b) 3f inhibited migration of MDA-MB-231 cells. (c) 3f inhibited invasion of MDA-MB-231 cells. (d) 3f inhibited lateral migration of MDA-MB-231 cells. Data are shown as mean ± SD from each group. Scale bars, 100 µm. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2020 |